When the disease first enters a herd, mass treatment with antibiotics (eg, tylosin, lincomycin, tiamulin, or a tetracycline) helps to control the severity of signs. When disease increases in endemic herds, treatment of individual pigs with antibiotics usually results in remission, presumably by controlling secondary bacteria. |
Inactivated mycoplasmal cultures have been developed as bacterins and consist of whole cell preparations as well as new subunit bacterins. These induce excellent protection against the development of gross lesions, and significantly reduce clinical signs (coughing) in growing pigs. Recent data indicate that prefarrowing vaccination of sows with M hyopneumoniae vaccines significantly reduces colonization of suckling piglets. |
The economic effects of the disease can be reduced, and sometimes eliminated, by improvements in housing and husbandry, particularly ventilation and overcrowding, along with medication and vaccination. “All-in/all-out” management of pigs from birth to market is extremely effective at reducing negative effects of disease; following this practice improves growth performance and reduces lung lesions. |
In large intensive units, starting with foundation stock free of mycoplasmal pneumonia and adopting strict precautions against direct and indirect contact with pigs from other herds is advisable. Unfortunately, many herds set up in this way do not remain free of mycoplasmas for very long, particularly in areas with a high density of pigs. Field observations suggest that infection can be windborne for at least a mile between large herds in cold, wet weather. |
In the USA and parts of Europe, most herds free of mycoplasmal pneumonia were established by the pig repopulation technique. More recently, some have been established by segregated early weaning. The biggest problems with these herd programs are the breakdown rate and the difficulty of monitoring herds that claim to be free of mycoplasmal pneumonia. Current hypotheses for these outbreaks suggest that certain herds may never have successfully eliminated the organism; rather, it coexisted within the population at an undetectable level for extended periods. Use of nasal swab PCR technology has demonstrated the presence of the organism in pigs free of clinical signs, lesions, and antibodies. Analysis of tracheal sections from these pigs by electron microscopy has indicated the presence of the organism on the cilia. |
|